CAS NO: | 357166-30-4 |
生物活性 | Pemetrexed disodium hemipenta hydrate is a novelantifolate, theKivalues of the pentaglutamate of LY231514 are 1.3, 7.2, and 65 nM for inhibitsthymidylate synthase(TS),dihydrofolate reductase(DHFR), and glycinamide ribonucleotide formyltransferase (GARFT), respectively. | ||||||||||||||||
IC50& Target | Ki: 1.3 nM (TS), 7.2 nM (DHFR), 65 nM (GARFT)[1] | ||||||||||||||||
体外研究 (In Vitro) | Pemetrexed (LY231514) disodium is a novel classical antifolate, the antitumor activity of which may result from simultaneous and multipie inhibition of several key folate-requiring enzymes via its polyglutamated metabolites. Pemetrexed (LY231514) is one of the best substrates that is known for the enzyme FPGS (Km=1.6 μM and Vmax/Km=621). It is likely that polyglutamation and the polyglutamated metabolites of LY231514 play profound roles in determining both the selectivity and the antitumor activity of this novel agent. Whereas LY23l5l4 only moderately inhibits TS (Ki=340 nM, recombinant mouse), the pentaglutamate of LY23l5l4 is 100-fold more potent (Ki=3.4 nM), making LY231514 one of the most potent folate-based TS inhibitors[1]. | ||||||||||||||||
体内研究 (In Vivo) | The group of mice treated with PC61 plus Pemetrexed demonstrates statistically longer survival than other groups. In a survival analysis, significantly better survival is observed in the group of mice treated with PC61 plus Pemetrexed compare with those treated with PC61 alone, rat IgG plus Pemetrexed, or no treatment[2]. | ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 516.41 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C20H24N5Na2O8.5 | ||||||||||||||||
CAS 号 | 357166-30-4 | ||||||||||||||||
中文名称 | 培美曲塞二钠2.5水合物 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) | ||||||||||||||||
溶解性数据 | In Vitro: H2O : 100 mg/mL(193.64 mM;Need ultrasonic) DMSO : 2 mg/mL(3.87 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
*以上所有助溶剂都可在本网站选购。 |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |